n-methyl-3,4-methylenedioxyamphetamine has been researched along with Migraine Disorders in 4 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seetohul, LN | 1 |
Pounder, DJ | 1 |
Bhattacharyya, S | 1 |
Schapira, AH | 1 |
Mikhailidis, DP | 1 |
Davar, J | 1 |
Trittibach, P | 1 |
Frueh, BE | 1 |
Goldblum, D | 1 |
Whitaker-Azmitia, PM | 1 |
1 review available for n-methyl-3,4-methylenedioxyamphetamine and Migraine Disorders
Article | Year |
---|---|
Drug-induced fibrotic valvular heart disease.
Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Mo | 2009 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Migraine Disorders
Article | Year |
---|---|
Four fatalities involving 5-IT.
Topics: Alcohol Drinking; Autopsy; Chromatography, High Pressure Liquid; Designer Drugs; Female; Forensic To | 2013 |
Bilateral angle-closure glaucoma after combined consumption of "ecstasy" and marijuana.
Topics: Adult; Cannabis; Emergency Medicine; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Illicit Dr | 2005 |
Depression to ecstasy. The Neuropharmacology of Serotonin sponsored by the New York Academy of Sciences, New York, NY, USA, July 10-13, 1989.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Mapping; Depression; Humans; Mental Disorders; Migrain | 1989 |